Neuronetics Inc

General ticker "STIM" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $34.6M

Neuronetics Inc does not follow the US Stock Market performance with the rate: -32.7%.

Estimated limits based on current volatility of 7.1%: low 1.26$, high 1.46$

Factors to consider:

  • Current price 21.1% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.68$, 4.63$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.55$, 4.37$]

Financial Metrics affecting the STIM estimates:

  • Negative: Non-GAAP EPS, $ of -1.07 <= 0.10
  • Negative: Operating profit margin, % of -29.98 <= 1.03
  • Negative: Operating cash flow per share per price, % of -35.14 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0.19 <= 0.74

Similar symbols

Short-term STIM quotes

Long-term STIM plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $55.31MM $65.21MM $71.35MM
Operating Expenses $82.88MM $100.32MM $101.90MM
Operating Income $-27.56MM $-35.11MM $-30.55MM
Non-Operating Income $-3.63MM $-2.05MM $0.36MM
Interest Expense $3.63MM $2.05MM $5.42MM
R&D Expense $7.92MM $9.34MM $9.52MM
Income(Loss) $-31.19MM $-37.16MM $-30.19MM
Profit(Loss) $-31.19MM $-37.16MM $-30.19MM
Stockholders Equity $85.17MM $57.06MM $34.19MM
Inventory $6.56MM $8.90MM $8.09MM
Assets $141.22MM $116.88MM $115.83MM
Operating Cash Flow $-27.98MM $-30.74MM $-32.04MM
Capital expenditure $2.35MM $3.27MM $2.37MM
Investing Cash Flow $-9.84MM $6.73MM $-1.32MM
Financing Cash Flow $83.01MM $0.21MM $22.70MM
Earnings Per Share* $-1.40 $-1.46 $-1.05

* EPS are Split Adjusted, recent splits may be reflected with a delay.